The future of patient-centricity in pharmacovigilance involves a dynamic flow of data and information revolving around patients and enabling them — and their caregivers — to make insights-b
The clinical trial industry is hyper-focused on enhancing the participant experience. We’ve seen buzzwords like “patient convenience” and marketing campaigns around “patient centricity”.
While patient centricity remains vital to the life sciences industry, as companies come under pressure to reduce their carbon footprint, we are increasingly seeing different aspects of the
It’s simple: a clinical trial health system that enrols more patients will lead to faster treatment advances and, therefore, better outcomes for people with cancer.1 But, as it s
Boehringer Ingelheim says it may have found the first therapy for diabetic macular ischaemia (DMI), a common and irreversible complication of the eye in people with diabet
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.